SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma gets NCLT’s approval for Scheme of Arrangement

11 Sep 2017 Evaluate

Sun Pharmaceutical Industries has received National Company Law Tribunal’s (NCLT) approval for Scheme of Arrangement among Sun Pharma Medisales, Ranbaxy Drugs, Gufic Pharma, Vidyut Investments (collectively known as ‘Transferor Companies’) and Sun Pharmaceutical Industries (the company) and their respective members and creditors (‘Scheme of Arrangement’).

The Company has filed the certified NCLT order with certified Scheme of Arrangement in E-form INC-28 with Registrar of Companies, Gujarat On September 08, 2017 and therefore, the Transferor Companies got merged with the Company with effect from September 08, 2017.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1872.40 25.10 (1.36%)
11-May-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1282.15
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2249.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×